Childhood psychosocial stress is linked with impaired vascular endothelial function, lower SIRT1, and oxidative stress in young adulthood.
Nathaniel D M Jenkins, Emily M Rogers, Nile F Banks...
https://pubmed.ncbi.nlm.nih.gov/34328346Actively Recruiting
Led by University of Iowa · Updated on 2025-11-24
300
Participants Needed
1
Research Sites
21 weeks
Total Duration
U
University of Iowa
Lead Sponsor
M
MitoQ Limited
Collaborating Sponsor
Adverse childhood experiences (ACEs), such as abuse and neglect during the first 18 years of life, are linked to a higher risk of cardiovascular diseases and death. This research investigates how mitochondrial dysfunction may contribute to impaired blood vessel function in young adults with a history of ACEs. The study aims to understand the biological causes of these vascular problems to help develop ways to reduce cardiovascular risks in affected individuals. Participants will receive either a single dose of a mitochondrial-targeted antioxidant supplement called Mitoquinone Mesylate (MitoQ) or a placebo. Before and after taking the supplement, blood vessel function will be measured using a special test called flow mediated dilation. Participants will then undergo a standardized psychosocial stress test while researchers collect blood samples and monitor vascular and stress responses to see if reducing mitochondrial oxidative stress improves these functions. During the study, participants will visit the lab to provide blood samples and undergo vascular function tests before and after supplementation. They will also be monitored during and after the stress test through blood pressure measurements, blood samples, and other cardiovascular assessments. The primary outcomes include changes in vascular function, blood pressure, endothelial cell microparticles, and cortisol levels, with additional measures of cardiac output and growth factors. The study will help identify how mitochondrial stress affects cardiovascular health in young adults with ACEs.
CONDITIONS
Probing the Role of Mitochondrial Oxidative Stress in Impaired Vascular Function Among Young Adults With Early Life Adversity
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day
Participants consume a single acute dose of either the mitochondrial targeted antioxidant supplement (MitoQ) or placebo. Vascular endothelial function and blood samples are collected before and after supplementation, followed by a standardized psychosocial stress test with additional blood sampling.
1 visit (in-person)
Total: 1 location
1
Integrative Laboratory of Applied Physiology and Lifestyle Medicine
Iowa City, Iowa, United States, 52242
Actively Recruiting
M
Manoela Lima Oliveria, PhD
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nathaniel D M Jenkins, Emily M Rogers, Nile F Banks...
https://pubmed.ncbi.nlm.nih.gov/34328346Shaoyong Su, Marcia P Jimenez, Cole T F Roberts...
https://pubmed.ncbi.nlm.nih.gov/26289252V J Felitti, R F Anda, D Nordenberg...
https://pubmed.ncbi.nlm.nih.gov/9635069